HALEOSLABS.NS

Haleos Labs Limited

NSEHealthcare

₹1,655.00

▲ +1.48%+₹24.10 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹1,630.90

Day range

₹0 – ₹0

52W range

₹1,181 – ₹1,774

Volume

1.4K

Avg vol (20D)

2.1K

Mkt cap

₹500.9Cr

P/E TTM

28.9×

Trade Haleos Labs Limited with Artha

Company Metrics

Revenue (ttm)₹333.79 Cr

Net Income (ttm)₹0.00

Shares Out30.23 L

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.36

About HALEOSLABS.NS

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

IndustryBiotechnology

SectorHealthcare

Employees0

Stock ExchangeNSE

Ticker SymbolHALEOSLABS.NS

Websitehttps://haleoslabs.com

HALEOSLABS.NS · NSE

Financial Performance

In 2026, Haleos Labs Limited's revenue was ₹333.79 Cr, an decrease of +15.70% compared to the previous year. Earnings were ₹0.00, an decrease of +85.40%.

Revenue (2026)

₹333.79 Cr

↘-15.70% YoY

Earnings (2026)

₹0.00

↘-85.40% YoY

Year-over-Year Growth

Revenue

-15.70%

Earnings

-85.40%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account